Penumbra Inc (PEN)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $12.65B
Last updated: Nov 17, 2026 at 4:20 PM ET
Penumbra Inc (PEN) Statistics
Penumbra (PEN) has a market cap of $12.65B and an enterprise value of $12.39B. Its trailing P/E is 77.1x.
Total Valuation
Enterprise value is 2.01% below the market cap, as cash exceeds debt.
| Market Cap | $12.65B |
|---|---|
| Enterprise Value | $12.39B |
| Latest price (Nov 17, 2026) | $319.13 |
Key Dates
| Last Earnings Date | Oct 29, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 8.1x and 7.9x. Its year-end P/E ranged from 81.0x to 795.5x from 2017 to 2025.
| P/E Ratio | 77.1x |
|---|---|
| Forward P/E | 69.6x |
| P/S Ratio | 8.1x |
| Forward P/S | 7.9x |
| P/B Ratio | 7.9x |
| P/TBV Ratio | 8.9x |
| P/FCF Ratio | 62.8x |
| P/OCF Ratio | 48.5x |
| PEG Ratio | 3.9 |
Enterprise Valuation
Counting debt and cash, the company is valued at 58.8x EBITDA and 61.5x free cash flow.
| EV / Earnings | 78.9x |
|---|---|
| EV / Sales | 7.9x |
| EV / EBITDA | 58.8x |
| EV / FCF | 61.5x |
Price Statistics
The stock is up 13.95% over 52 weeks and trades 0.31% below its 50-day average.
| Beta (1Y) | 0.19 |
|---|---|
| 52-Week Change | +13.95% |
| 1-Month Change | -1.02% |
| 3-Month Change | -2.36% |
| 6-Month Change | -2.27% |
| 5-Year Change | +15.33% |
| 10-Year Change | +383.62% |
| Total Return (1Y) | +13.95% |
| Total Return (3Y CAGR) | +12.14% |
| Total Return (5Y CAGR) | +4.17% |
| Return vs SPY (1Y) | +3.19% |
| Max Drawdown (1Y) | -12.23% |
| Max Drawdown (3Y) | -40.09% |
| Sharpe Ratio (1Y) | 0.73 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $320.11 |
| 200-Day Average | $325.33 |
| 52-Week Range | $276.72 to $362.41 |
| RSI (14 Days) | 44.8 |
| Average Volume (20 Days) | 393.36K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.89x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 5.89x |
|---|---|
| Quick Ratio | 3.92x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 9.92% over the last 12 months, against a 5-year average of 4.29%.
| Return on Equity (ROE) | 9.92% |
|---|---|
| Return on Assets (ROA) | 7.75% |
| ROE (5Y Average) | 4.29% |
| ROA (5Y Average) | 3.31% |
| ROIC (5Y Average) | 12.45% |
| Asset Turnover | 0.83x |
| Inventory Turnover | 1.11x |
| Receivables Turnover | 8.09x |
| Cash Conversion Cycle | 343 days |
Taxes
Income tax took 24.47% of pretax income over the last 12 months.
| Income Tax (TTM) | $50.85M |
|---|---|
| Effective Tax Rate | 24.47% |
Scores
PEN has an Altman Z-Score of 19.08, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 19.08 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $1.56B over the last 12 months is up 16.98% from the 12 months before.
| Revenue | $1.56B |
|---|---|
| Revenue Growth (YoY) | +16.98% |
| Gross Profit | $1.06B |
| Operating Income | $189.25M |
| Pretax Income | $207.82M |
| Net Income | $157.02M |
| EBITDA | $209.36M |
| Reported EPS (TTM) | $4.14 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 77.83% of the $2.03B in total assets.
| Cash and Equivalents | $254.28M |
|---|---|
| Total Debt | $0 |
| Net Cash | $254.28M |
| Net Cash Per Share | $6.45 |
| Working Capital | $1.14B |
| Shareholder Equity | $1.58B |
| Book Value Per Share | $40.19 |
| Tangible Book Value | $1.41B |
| Tangible Book Per Share | $35.82 |
| Total Assets | $2.03B |
| Total Liabilities | $441.59M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $60.75M of capital spending, operating cash flow left $200.29M of free cash flow.
| Operating Cash Flow | $261.05M |
|---|---|
| Capital Expenditures | $60.75M |
| Free Cash Flow | $200.29M |
| FCF Per Share | $5.08 |
| Depreciation and Amortization | $20.12M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 12.13%, against a 5-year average of 4.18%.
| Gross Margin | 67.98% |
|---|---|
| Operating Margin | 12.13% |
| Pretax Margin | 13.32% |
| Net Margin | 10.06% |
| EBITDA Margin | 13.42% |
| FCF Margin | 12.84% |
| Gross Margin (5Y Average) | 64.32% |
| Operating Margin (5Y Average) | 4.18% |
| Net Margin (5Y Average) | 4.51% |
Growth
Revenue grew 18.33% a year over 3 years, and EPS 182.68% a year.
| Revenue Growth (3Y CAGR) | +18.33% |
|---|---|
| Revenue Growth (5Y CAGR) | +20.16% |
| EPS Growth (3Y CAGR) | +182.68% |
| EPS Growth (5Y CAGR) | +77.17% |
| Operating Income Growth (3Y CAGR) | +214.53% |
| Book Value Per Share Growth (2Y CAGR) | +9.90% |
| Tangible Book Per Share Growth (2Y CAGR) | +15.28% |
Dividends and Yields
PEN does not pay a dividend. Its free cash flow yield is 1.59%.
| Earnings Yield | 1.30% |
|---|---|
| FCF Yield | 1.59% |
| Buyback Yield | -0.06% |
| Shareholder Yield | -0.06% |
Peer Position
Against 8 similar companies, PEN has the highest P/E.
P/E RatioPeer median 22.8x
P/S RatioPeer median 3.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.55%
| P/E Ratio | 77.1x vs 22.8x median |
|---|---|
| P/S Ratio | 8.1x vs 3.2x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +16.98% vs +5.55% median |
Analyst Forecast
Consensus estimates put revenue growth at 13.57% and EPS growth at 26.71% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +13.57% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +26.71% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PEN
What is PEN's market cap?
Penumbra has a market cap of $12.65B. Its enterprise value, which adds debt and subtracts cash, is $12.39B.
What is PEN's P/E ratio?
Penumbra has a trailing P/E ratio of 77.1x and a forward P/E of 69.6x.
How many shares of PEN are outstanding?
Penumbra has 39.40M shares outstanding. The count is up 0.83% from a year earlier.
Does PEN pay a dividend?
No. Penumbra does not pay a dividend.
How much debt does PEN have?
Penumbra has $0 of total debt and $254.28M of cash and equivalents, a net cash position of $254.28M.
PEN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts